Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis.
Konsta, Maria; Bamias, Giorgos; Tektonidou, Maria G; Christopoulos, Panayiotis; Iliopoulos, Alexios; Sfikakis, Petros P.
; 52(3): 448-51, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23204549
Correspondence of vitamin D status with functional scores and disease activity among Croatian patients with ankylosing spondylitis: a preliminary study.
Sulfasalazine for ankylosing spondylitis.
Methotrexate for ankylosing spondylitis.
[A study on calculating the ankylosing spondylitis disease activity score according to the C-reactive protein level].
Serum prolidase level in ankylosing spondylitis: low serum levels as a new potential gold standard biomarker for disease activity.
Observational study on the QUality of life of Italian Axial SpondyloARthritis patients (QUASAR): baseline data.
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety.
Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.
[Efficacy of Yisaipu tapering in the treatment of ankylosing spondylitis].